Abbott Q3 Results Fall Short of Sales Forecast
Abbott (NYSE: ABT) shares declined before hours due to third-quarter results that did not meet the consensus Wall Street forecast.
Shares of ABT fell 2.7% to $129.10 in pre-market trading and continued to dip by 3.2% to $128.35 by midday, closing at $129.46.
The company reported profits of $1.64 billion, or 94¢ per share, on sales of $11.37 billion for the quarter ended September, with a 6.9% sales increase and 0.1% bottom line dip year-over-year.
Adjusted earnings per share were $1.30, meeting Wall Street expectations, but sales fell short of the projected $11.39 billion in revenue.
Abbott’s Medical Device sales grew 15%.
Author's summary: Abbott's Q3 results fell short of sales forecast.
More News
- Scott Parker's 'polar opposite' Newcastle United verdict
- Marvin Vettori “The Italian Dream”
- Scott Parker says there is a real calmness at Burnley
- Newcastle 2-1 Burnley: Scott Parker post-match interview
- Bridging Generations in B&NES to commemorate Holocaust Memorial Day 2026
- View from the Opposition: Scott Parker on the challenge Palace pose
- Newcastle 2-1 Burnley: What Parker said
- Scott Parker Newcastle Press Conference
- Awareness walk held to commemorate INT'L Anti-Corruption Day
- Time to talk about Bruno! Brunno Ferreira defeats Marvin Vettori by Unanimous Decision